Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Kura Oncology, Inc. (KURA) had Earnings per Share (EPS) (Basic) of $-3.18 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$67.48M |
|
$-278.67M |
|
$0.06M |
|
$67.42M |
|
$371.11M |
|
$-303.63M |
|
$25.26M |
|
$-278.37M |
|
$-278.37M |
|
$-278.67M |
|
$-278.67M |
|
$-278.67M |
|
$-278.67M |
|
$-303.63M |
|
$-311.09M |
|
87.68M |
|
87.68M |
|
|
Earnings per Share (EPS) (Basic) |
$-3.18 |
$-3.18 |
|
| Balance Sheet Financials | |
$708.66M |
|
$7.86M |
|
$29.70M |
|
$738.36M |
|
$116.97M |
|
$9.71M |
|
$447.25M |
|
$564.23M |
|
$174.13M |
|
$174.13M |
|
$174.13M |
|
87.86M |
|
| Cash Flow Statement Financials | |
$-64.06M |
|
$-13.10M |
|
$1.79M |
|
$224.46M |
|
$149.10M |
|
$-75.36M |
|
$37.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.06 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
99.92% |
|
-449.94% |
|
-449.94% |
|
-460.99% |
|
-412.51% |
|
-412.95% |
|
$-70.70M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.14 |
|
7.66 |
|
47.62 |
|
-160.03% |
|
-160.03% |
|
-37.74% |
|
-151.58% |
|
$1.98 |
|
$-0.81 |
|
$-0.73 |
|